The Real-World Impact of CAR T-Cell Therapy in Large B-Cell LymphomaApril 5th 2024Experts explore the clinical significance and practical implications of recent findings regarding a CAR T-cell therapy in real-world settings.
Post-Conference Perspectives: Updates on TIL Therapy for Solid Tumors, Including Melanoma and NSCLCFebruary 3rd 2023Expert perspectives from Amod Sarnaik, MD, and Krishna Komanduri, MD, on the evolving role of tumor-infiltrating lymphocyte therapy in solid tumors, following the Society for Immunotherapy of Cancer (SITC) 2022 meeting.
Emerging CAR-T Therapies in Large B-cell Lymphomas (LBCL): Highlights from ASH 2022 and BeyondJanuary 27th 2023Experts review key updates in LBCL management from the ASH 2022 annual meeting.